Body Interact was featured during the European Society of Cardiology conference, in Rome.

It supported highly interactive clinical case discussions with large audiences in two scientific sessions:  “Oral anticoagulation + specific reversal = more control” and “NOACS are not all the same: new factors to consider in 2016”.

These events were sponsored by Boehringer Ingelheim.